Update on CARDIO-TTRansform Phase 3 trial of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. CSX
6. GOOG
7. IBM
8. KNX
9. LVS
10. INTC

Go back to Update on CARDIO-TTRansform Phase 3 trial of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathy
(NASDAQ: IONS) Delayed: 57.08 +3.07 (5.68%)
Previous Close $54.01    52 Week High $62.68 
Open $53.71    52 Week Low $19.59 
Day High $57.25    P/E N/A 
Day Low $53.35    EPS $0.00 
Volume 1,135,891